New CEO Mike Doustdar is kitchen-sinking the costs of restructuring the company to focus on diabetes and anti-obesity drugs.
www.marketwatch.com
#Weightloss #drug #manufacturer #Novo #Nordisk #cuts #jobs #profit #forecast
Weight-loss drug manufacturer Novo Nordisk cuts 9000 jobs — and its profit forecast
